Heartbeat Health, a NYC-based healthcare company working to deliver heart care, raised $20m in Series B funding.
The round was led by Echo Health Ventures, with participation from DaVita Venture Group and existing investors, .406 Ventures, Optum Ventures, Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures. Jessica Zeaske, a Partner at Echo Health Ventures, will join the Board of Directors at Heartbeat.
The company intends to use the funds to accelerate product research and development as well as expand clinical services offered to at-risk organizations.
Led by Dr. Jeff Wessler, CEO, Nayan Jain, CTO, and Mark Hanson, Chief Product Officer, Heartbeat Health is a healthcare technology company that delivers virtual-first cardiovascular disease prevention and management with a focus on improved clinical experience, health outcomes, and reduced cost. The Heartbeat virtual-first platform offers a data-powered patient and provider experience, combining telemedicine, diagnostic coordination, medication management, lifestyle guidance, and stakeholder engagement.